The Agency for Toxic Substances and Disease Registry (ATSDR) is a public health agency with responsibility for assessing the public health implications associated with uncontrolled releases of hazardous substances into the environment. The biological effects of low-level exposures are a primary concern in these assessments. One of the tools used by the agency for this purpose is the risk assessment paradigm originally outlined and described by the National Academy of Science in 1983. Because of its design and inherent concepts, risk assessment has been variously employed by a number of environmental and public health agencies and programs as a means to organize information, as a decision support tool, and as a working hypothesis for biologically based inference and extrapolation. Risk assessment has also been the subject of significant critical review. The ATSDR recognizes the utility of both the qualitative and quantitative conclusions provided by traditional risk assessment, but the agency uses such estimates only in the broader context of professional judgment, internal and external peer review, and extensive public review and comment. This multifaceted approach is consistent with the Council on Environmental Quality's description and use of risk analysis as an organizing construct based on sound biomedical and other scientific judgment in concert with risk assessment to define plausible exposure ranges of concern rather than a single numerical estimate that may convey an artificial sense of precision. In this approach biomedical opinion, host factors, mechanistic interpretation, molecular epidemiology, and actual exposure conditions are all critically important in evaluating the significance of environmental exposure to hazardous substances. As such, the ATSDR risk analysis approach is a multidimensional endeavor encompassing not only the components of risk assessment but also the principles of biomedical judgment, risk management, and risk communication. Within this framework of risk analysis, the ATSDR may rely on one or more of a number of interrelated principles and approaches to screen, organize information, set priorities, make decisions, and define future research needs and directions.
Introduction
The Agency for Toxic Substances and Human Services. The ATSDR mission is to Disease Registry (ATSDR) is one of eight prevent exposure and adverse human health agencies of the U.S. Public Health Service effects and diminished quality of life associwithin the U.S. Department of Health and ated with exposure to hazardous substances from waste sites, unplanned releases, and other sources of pollution present in the environment (1) . Pursuant to its responsibilities mandated by the Comprehensive Environmental Response, Compensation, and Liability Act, also known as Superfund, the agency addresses public health concerns associated with a wide range of low-level exposures to substances found at hazardous waste facilities.
The ATSDR, like other agencies such as the U.S. Environmental Protection Agency (U.S. EPA) and the U.S. Food and Drug Administration (U.S FDA), has relied on risk assessment in its task of assessing the public health implications of low-level exposures to hazardous substances. As defined by the National Academy of Sciences in 1983, risk assessment consists of four interrelated steps or components: hazard identification, dose-response assessment, exposure assessment, and risk characterization (2) . In the real-life risk assessment process, the fourth step, risk characterization, is actually an integration of the other three components into a qualitative and/or quantitative assessment that characterizes the probability of adverse health effects in an exposed population. The ATSDR approach for risk characterization of noncancer adverse health effects is primarily a qualitative rather than a probabilistic undertaking. Nevertheless, the ATSDR does use minimal risk levels (MRLs), health guidance values developed by the ATSDR specifically to identify levels of exposure thought to be without appreciable risk over specified durations and routes of exposure (3) . Although the procedures used to derive such health guidance values by agency scientists is operationally straightforward, the judgment that goes into development of these values is guided by a full range of expert judgment in the fields of toxicology, epidemiology, and pathology, as detailed below.
In this paper we discuss the role of health guidance values in public health practice and the application of mechanistic insights in deriving health guidance values. Three questions posed are vital to how regulatory and public health agencies consider the biological effects of low-level exposures (4) : * Does the understanding of the mechanisms of toxicity affect how agencies assess risks from exposures to toxic substances?
exposures to toxic substances affect how the ATSDR assesses risks from exposures to toxic substances? If low doses of toxic agents induce apparently beneficial responses (e.g., enhanced longevity, lower incidence of disease), how does and/or could the ATSDR address this? We conclude these discussions by outlining some future directions being pursued by the ATSDR to expand and strengthen the practical application of biologically based inference and extrapolation to the risk characterization and analysis of environmental exposures to hazardous wastes.
Risk Analysis as an Organizing Construct to Promote Optimal Decisions
The ATSDR uses risk assessment and associated health guidance values in the context of risk analysis as defined by the Council on Environmental Quality (5) . Within this framework, risk analysis is an organizing construct based on sound biomedical and other scientific judgment as well as on risk assessment and is used to define plausible ranges of concern rather than single numerical conclusions, which often are misinterpreted. In this approach actual exposure conditions are critically important to the process of evaluating the significance of environmental exposures to hazardous substances (6) .
As applied by the ATSDR in public health practice, risk analysis is a multidimensional endeavor encompassing the concepts of risk assessment, biomedical judgment, risk management, and risk communication ( Figure 1 ). Its application can be visualized within the broader context of the agency's public health assessment program ( Figure 2 ). As part of its public health mission, the ATSDR develops public health assessments to evaluate the public health implications of all hazardous waste sites on the National Priorities List (NPL) and for selected sites identified by public petition (1 specifically to determine which chemicals should be addressed further in terms of risk posed to exposed communities based on a comparison with environmental monitoring data. Depending on the outcome of the ATSDR analysis, a number of followup activities might be considered. Possible follow-up activities may include further health study and/or surveillance, health education, research, and the development of chemical-specific exposure registries.
Derivation of Health Guidance Values
The ATS.DR derives chemical-specific health guidance values known as MRLs for oral and inhalation routes of exposure to assist and guide health assessors in evaluating contaminants of concern at hazardous waste sites. An MRL is defined as "an estimate of the daily human exposure to a substance that is likely to be without an appreciable risk of adverse, noncancer effects over a specified duration of exposure" (3) . Depending on the availability of appropriate data, MRLs are calculated for both oral and inhalation routes of exposure and for three specific durations of exposure: acute ( reference doses/reference concentrations (RfDs/RfCs) developed by the U.S. FDA and the U.S. EPA, respectively. Specific internal guidance for derivation of MRLs by the ATSDR has been published (3).
Traditionally, health guidance values have been derived from either controlled human clinical studies, human epidemiologic studies (usually retrospective), or controlled studies involving laboratory animals serving as surrogates for human populations. Based on a review of these studies, the lowest dose or exposure level at which an effect considered adverse was observed (LOAEL) and the highest level below which no adverse effect was observed (NOAEL) is similarly determined. Because the population of interest in the health study typically is not the same as a potentially exposed population to be protected by the health guidance value, mathematical adjustments are made to the LOAEL or NOAEL to express uncertainties inherent in the assumptions and database used to calculate the health guidance value.
The uncertainty factors (UFs) proposed by Barnes Table 2 .
Absorption/Bioavailability. 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN (TCDD). The ATSDR has developed a proposed acute oral MRL for TCDD based on a study in mice exposed to 14 daily doses of TCDD by gavage in oil vehicle (9) . An important issue considered during derivation of this MRL was the bioavailability ofTCDD (10) : It has been well documented in animal studies that adsorption of TCDD from the gastrointestinal tract depends largely on the carrier vehicle (11) . Absorption of TCDD from both soil and feed has been estimated to be 20 to 60%, whereas the adsorption of TCDD from a corn oil vehicle has been estimated to be as much as 85%. Because the likely means of environmental exposure to TCDD is through ingestion of contaminated food or soil but the definitive animal TCDD toxicity study used corn oil gavage, MRL derivation (18) . However, 1,1, 1-trichloroethane is rapidly eliminated in the expired air and blood levels of 1,1,1-trichloroethane plateau after 2 to 3 hr (18) . These findings suggest that longer exposure would not lead to higher body burdens. Therefore, a correction for intermittent exposure was considered inappropriate for the acute-duration inhalation MRL for 1,1, 1-trichloroethane (19) .
HEXACHLOROETHANE. An acuteduration inhalation MRL was derived for hexachloroethane based on an NOAEL for neurological effects reported in pregnant rats exposed to hexachloroethane (20) . Laboratory data showed that effects depend on blood levels, which directly depend on concentration, not duration of treatment (21) . Moreover, the toxicokinetic data also showed a rapid turnover in the tissues. Therefore, no adjustment was made to the MRL to correct for intermittent exposure.
VINYL CHLORIDE. An acute-duration inhalation MRL was derived for vinyl chloride based on developmental effects in offspring of mice exposed during gestation (22, 23 ). An intermediate-duration inhalation MRL was also derived based on hepatic effects in rats (24) . A review of the toxicokinetic data indicated that vinyl chloride readily reaches steady state, is rapidly metabolized and excreted, and neither it nor its metabolites readily accumulate in tissue (25) (37) . Many of these substances have been shown to be toxic at high exposure levels but appear to be beneficial at much lower exposure levels. Such substances include not only dietary essential trace elements such as manganese, fluoride, chromium, zinc, and selenium but also a diverse spectrum of purported hormetic agents such as carbon tetrachloride, chloroform, cyanide, heavy metals, polychlorinated biphenyls, and insecticides (38, 39) . Because many of these substances are common contaminants at a number of toxic waste sites, they present a variety of unique problems for public health assessments at those sites.
As previously mentioned, the ATSDR carefully considers the biological effects of low-level exposures in its human health assessments, particularly in those deliberations involving the derivation of MRLs. Any evidence of hormesis (i.e., the induction of beneficial effects by low doses of otherwise harmful physical or chemical agents) has always been carefully noted and considered in these deliberations. However, even though the concept of hormesis has been the subject of extensive scientific debate in recent years (40, 41) , it still is not known whether hormetic effects occur with most toxicological end points (e.g., carcinogenesis, immunotoxicity, mutagenesis, teratogenesis) or whether hormetic effects occur at the same site of action for both low and high levels of exposure.
Nonetheless, the fact remains that many chemicals on the ATSDR list of hazardous substances known to be toxic at high exposure levels can cause deficiency associated toxicity if exposure levels are extremely low or absent (e.g., chromium, manganese, zinc). For each substance in its MRL deliberations the ATSDR considers not only high-dose toxicity but also any evidence of essentiality or beneficial effects as well as any evidence ofdeficiency associated toxicity.
The best known and understood chemical substances identified as beneficial at extremely low doses are dietary essential trace element(s) (ETE), i.e., chemical substances that must be present in small quantities in the human diet to maintain normal physiological functions. For each ETE, two ranges of exposure or intake are associated with adverse health effects: intakes that are too low and result in nutritional deficiency and intakes that are too high and cause toxicity. Some examples of the types of information considered by the ATSDR in derivation of oral MRLs for a number of ETEs are discussed below.
Chromium
Chromium enters the environment in several different forms. Cr(III) is an essential nutrient that acts as a cofactor for insulin and helps the body use sugar, protein, and fat (required for normal energy metabolism). Cr(VI), however, generally is considered harmful and is produced only from anthropogenic sources. Usually a substantial margin of safety exists between the amount of Cr(III) normally consumed and the amount considered to have harmful effects. High levels of Cr(VI) have been reported to increase the incidence of bronchial cancer in workers exposed to chromate dusts (42) and to cause sensitization, asthma, and dermatitis. Humans cannot oxidize the nontoxic Cr(III) to the potentially carcinogenic Cr(VI); however, Cr(VI) can be reduced to Cr(III) after penetration of biological membranes and in the gastric environment and therefore there has been some difficulty in distinguishing between the effects of the two Cr forms (43) .
In a number of animal studies severe Cr deficiency in animal studies has resulted in hyperglycemia, decreased weight gain, elevated serum cholesterol levels, aortic plaques, corneal opacities, impaired fertility, and lethality (43) . For humans the estimated safe and adequate daily intake (ESADDI) is 50 to 200 pg (44). In highdose studies in mice with either chromium sulfate or potassium dichromate, the most sensitive toxic end point observed was decreased spermatogenesis (45) . However, this end point was classified by the ATSDR as a serious effect and therefore inappropriate for derivation of an MRL (3, 43) . Because of the lack of data appropriate for deriving an MRL, the ATSDR adopted the upper limit of the ESADDI-200 pg Cr/day-as an interim health guidance value for Cr(III) and Cr(aVI). Such guidance was deemed both appropriate and necessary because of the prevalence of Cr at hazardous waste sites, the fairly complete database on Cr, and the fact that Cr is an essential nutrient.
Manganese
Manganese is a constituent of several metalloenzymes (arginase, pyruvate carboxylase, and manganese superoxide dismutase) and an enzyme activator (hydrolases, kinases, decarboxylases, and transferases) (44, 46, 47) . It is required for normal brain function. Although Mn is an essential nutrient, exposure to high levels through inhalation or ingestion may cause adverse health effects. Inhalation of high Mn concentrations in dust or fumes, not dietary intake, is the primary exposure route associated with toxicity in humans (48) . Toxicity in humans can be manifest as a crippling neurologic disorder of the extrapyramidal system, with morphological lesions reminiscent of Parkinson's disease (49) . In addition to nervous system damage, reproductive and immune dysfunction, nephritis, testicular damage, pancreatitis, lung disease, and hepatic damage can also occur (49) . In domestic animals iron deficiency has also occurred as a result of the inhibitory effect of Mn on iron absorption (50 (55) . Supplementation with amounts many times the recommended daily allowance (5) resulted in impairment of various immune responses (56) and caused a decline in high-density lipoproteins in serum (57) . Conversely, Zn deficiency causes growth and developmental retardation in humans (58, 59) , reduced immune function (60) , and reproductive failure and teratogenesis in animals (51 (69) . Because the purpose of the BMD model is to derive an estimate of dose for a given incidence that is likely to fall within a predetermined experimental dose range, and because the model does not require extrapolation to estimates far below the experimental dose range, the degree of uncertainty in the dose estimates is lessened. Depending on the end point and acceptable response level selected, using the BMD model may obviate the need for a default UF of 10 for LOAEL-to-NOAEL extrapolation (68, 70) .
The ATSDR's current intermediate oral MRL of 0.002 mg/kg/day for inorganic mercury was based on an NOAEL for increased kidney weight in rats divided by a UF of 100 (10 for animal-to-human extrapolation and 10 for human variability) (71) . In a BMD analysis of inorganic mercury studies recently conducted by the ATSDR, relative kidney weight was used as the response to calculate BMDs from the same study using the Weibull model. Application of 100-fold UF for intra-and interspecies variability yielded the following BMD-based intermediate oral MRL for inorganic mercury: 0.003 mg/kg/day for an estimated 10% risk, 0.002 mg/kg/day for an estimated 5% risk, and 0.0003 mglkg/day for an estimated 1% risk.
In this case, the BMD-based intermediate oral MRL for an estimated 5% risk was the same as the ATSDR's current MRL.
Functional Toxicology
Through an interagency agreement with the National Institute of Environmental Health Sciences, the ATSDR is pursuing development of functional toxicology assays to screen chemicals. These screens are comprised of human or animal cell lines transfected with a specific receptor gene along with a reporter gene. The purpose of these in vitro screens is to provide an assessment of the degree to which a single chemical or chemical mixture might exhibit some specific functional activity (e.g., estrogenic activity or dioxinlike activity). It is hoped that this approach eventually will permit priority chemicals and/or chemical mixtures to be evaluated on the basis of functional activity such as receptor binding, receptor occupancy, or gene activation rather than traditional whole-animal bioassay results (72 Qualitative (type of toxicity) and semiquantitative (direction of response not specific magnitude) evaluations have been prepared on binary weight-of-evidence combinations of chemicals included in two four-component mixture studies conducted by the TNO. These evaluations were used to estimate the overall toxicities of the mixtures that were then compared with experimentally determined toxicities (74, 75) . Preliminary analyses of the data indicate that the WOE approach quantitatively accounts for the observed interactions for mixtures of similarly acting renal toxicants, but for dissimilarly acting renal toxicants the method performs less well. This could be attributed to the fact that WOE evaluations are based on dose additivity that postulates that all chemicals in a given mixture act in the same way by the same mechanism and differ only in their potencies. Therefore, although this approach may be inappropriate for evaluating interactions for dissimilar acting agents, it may hold promise as a means to identify agents having different mechanisms of action.
Conclusions
The ATSDR believes that because it is a public health agency it is vitally important to continue to expand and improve its understanding and practical application of mechanistic principles to the risk analysis of hazardous environmental exposures. Mechanistic factors that must be considered in this process include specific chemical speciation, bioavailability, toxicokinetics and toxicodynamics, adaptive responses, hormesis and essentiality, and interactive effects of chemical mixtures. As was previously pointed out in Johnson and Jones (76) , it is essential to continue to invest in programs that expand our understanding of these mechanisms so that both our "risk assessments and science policies can be adjusted in light of new and better scientific data."
